TrialJournal of acquired immune deficiency syndromes (1999)2013

Safety, tolerability, and immunogenicity of repeated doses of dermavir, a candidate therapeutic HIV vaccine, in HIV-infected patients receiving combination antiretroviral therapy: results of the ACTG 5176 trial.

Benigno Rodriguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.